BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37193867)

  • 41. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus.
    Le Vasseur M; Ran I; Lacaille JC
    Neuroscience; 2008 Jan; 151(1):28-42. PubMed ID: 18035501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal Deprivation in Rats Decreases the Expression of Interneuron Markers in the Neocortex and Hippocampus.
    Aksic M; Poleksic J; Aleksic D; Petronijevic N; Radonjic NV; Jakovcevski M; Kapor S; Divac N; Filipovic BR; Jakovcevski I
    Front Neuroanat; 2021; 15():670766. PubMed ID: 34168541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Schizophrenia-associated SAP97 mutations increase glutamatergic synapse strength in the dentate gyrus and impair contextual episodic memory in rats.
    Kay Y; Tsan L; Davis EA; Tian C; Décarie-Spain L; Sadybekov A; Pushkin AN; Katritch V; Kanoski SE; Herring BE
    Nat Commun; 2022 Feb; 13(1):798. PubMed ID: 35145085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.
    Li W; Ghose S; Gleason K; Begovic A; Perez J; Bartko J; Russo S; Wagner AD; Selemon L; Tamminga CA
    Am J Psychiatry; 2015 Apr; 172(4):373-82. PubMed ID: 25585032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.
    Bitanihirwe BK; Lim MP; Kelley JF; Kaneko T; Woo TU
    BMC Psychiatry; 2009 Nov; 9():71. PubMed ID: 19917116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus.
    Benes FM
    Biol Psychiatry; 1999 Sep; 46(5):589-99. PubMed ID: 10472413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postsynaptic induction and presynaptic expression of group 1 mGluR-dependent LTD in the hippocampal CA1 region.
    Watabe AM; Carlisle HJ; O'Dell TJ
    J Neurophysiol; 2002 Mar; 87(3):1395-403. PubMed ID: 11877514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletion of dopamine D
    Tomasella E; Bechelli L; Ogando MB; Mininni C; Di Guilmi MN; De Fino F; Zanutto S; Elgoyhen AB; Marin-Burgin A; Gelman DM
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3476-3481. PubMed ID: 29531031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electron Microscopic Analysis of Hippocampal Axo-Somatic Synapses in a Chronic Stress Model for Depression.
    Csabai D; Seress L; Varga Z; Ábrahám H; Miseta A; Wiborg O; Czéh B
    Hippocampus; 2017 Jan; 27(1):17-27. PubMed ID: 27571571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons.
    Chang MC; Park JM; Pelkey KA; Grabenstatter HL; Xu D; Linden DJ; Sutula TP; McBain CJ; Worley PF
    Nat Neurosci; 2010 Sep; 13(9):1090-7. PubMed ID: 20729843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic evidence for the adhesion protein IgSF9/Dasm1 to regulate inhibitory synapse development independent of its intracellular domain.
    Mishra A; Traut MH; Becker L; Klopstock T; Stein V; Klein R
    J Neurosci; 2014 Mar; 34(12):4187-99. PubMed ID: 24647940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synaptic reorganization of calbindin-positive neurons in the human hippocampal CA1 region in temporal lobe epilepsy.
    Wittner L; Eross L; Szabó Z; Tóth S; Czirják S; Halász P; Freund TF; Maglóczky ZS
    Neuroscience; 2002; 115(3):961-78. PubMed ID: 12435433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypothalamic Supramammillary Nucleus Selectively Excites Hippocampal CA3 Interneurons to Suppress CA3 Pyramidal Neuron Activity.
    Li M; Kinney JL; Jiang YQ; Lee DK; Wu Q; Lee D; Xiong WC; Sun Q
    J Neurosci; 2023 Jun; 43(25):4612-4624. PubMed ID: 37117012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.
    Nguyen R; Morrissey MD; Mahadevan V; Cajanding JD; Woodin MA; Yeomans JS; Takehara-Nishiuchi K; Kim JC
    J Neurosci; 2014 Nov; 34(45):14948-60. PubMed ID: 25378161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced perisomatic inhibition and impaired long-term potentiation in the CA1 region of juvenile CHL1-deficient mice.
    Nikonenko AG; Sun M; Lepsveridze E; Apostolova I; Petrova I; Irintchev A; Dityatev A; Schachner M
    Eur J Neurosci; 2006 Apr; 23(7):1839-52. PubMed ID: 16623841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
    Du Y; Grace AA
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27432008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NMDA Receptors Containing GluN2B/2C/2D Subunits Mediate an Increase in Glutamate Release at Hippocampal CA3-CA1 Synapses.
    Prius-Mengual J; Pérez-Rodríguez M; Andrade-Talavera Y; Rodríguez-Moreno A
    Mol Neurobiol; 2019 Mar; 56(3):1694-1706. PubMed ID: 29916144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Properties and dynamics of inhibitory synaptic communication within the CA3 microcircuits of pyramidal cells and interneurons expressing parvalbumin or cholecystokinin.
    Kohus Z; Káli S; Rovira-Esteban L; Schlingloff D; Papp O; Freund TF; Hájos N; Gulyás AI
    J Physiol; 2016 Jul; 594(13):3745-74. PubMed ID: 27038232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.
    Roberts RC; McCollum LA; Schoonover KE; Mabry SJ; Roche JK; Lahti AC
    Schizophr Res; 2022 Nov; 249():4-15. PubMed ID: 32014360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.